Section Arrow
HUMA.NASDAQ
- Humacyte
(Financial Status)
Quotes are at least 15-min delayed:2026/06/01 14:19 EDT
Regular Hours
Last
 1.46
+0.16 (+12.31%)
Day High 
1.4699 
Prev. Close
1.3 
1-M High
1.34 
Volume 
8.88M 
Bid
1.45
Ask
1.46
Day Low
1.29 
Open
1.3 
1-M Low
0.8001 
Market Cap 
288.62M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.05 
20-SMA 1.02 
50-SMA 0.83 
52-W High 2.93 
52-W Low 0.5469 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.63/-0.31
Enterprise Value
351.04M
Balance Sheet
Book Value Per Share
0.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.04M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AIMAIM ImmunoTech Inc.0.8531+0.4453+109.20%-- 
OTLKOutlook Therapeutics0.8626+0.1326+18.16%-- 
RXRXRecursion Pharmaceuticals3.7478+0.1578+4.40%-- 
GNTAGenenta Science SpA1.7301+0.7001+67.97%-- 
IBRXImmunityBio7.195-0.325-4.32%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.